folic acid has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (39.29) | 24.3611 |
| 2020's | 17 (60.71) | 2.80 |
| Authors | Studies |
|---|---|
| Jedlovszky-Hajdu, A; Kohidai, L; Kovacs, N; Krisch, E; Mathe, D; Molnar, K; Nagy, KS; Pallinger, E; Puskas, JE; Szigeti, K; Takacs, A; Toth, K; Veres, DS | 1 |
| Jang, ES; Jeong, MS; Manivasagan, P; Saravanakumar, K; Sathiyaseelan, A; Wang, MH | 1 |
| Ghahremani, F; Hosseini, M; Jolfaie, NA; Kefayat, A; Rafienia, M | 1 |
| Chowdhury, M; Das, PK; Ghosh, A; Ghosh, AK | 1 |
| Chen, Y; Fan, S; Hu, X; Peng, J; Ren, S; Shen, X; Sun, R; Zhou, J | 1 |
| Adibfar, S; Gholizadeh Navashenaq, J; Hassannia, H; Hojjat-Farsangi, M; Izadi, S; Jadidi-Niaragh, F; Karpisheh, V; Masjedi, A; Mohammadi, H; Nazer, A; Rashidi, B; Tarokhian, H | 1 |
| Bakhtiari, MR; Ma'mani, L; Parnian, J; Safavi, M | 1 |
| Chen, J; Li, Z; Wang, C; Wang, H; Wang, Q; Yang, X; Yu, X; Zeng, H; Zhang, Z | 1 |
| Dong, ZQ; Han, MM; Li, N; Li, Y; Liu, T; Lv, S; Wu, JJ; Xiong, YX; Ye, F; Ye, HY; Zhang, Y; Zhang, YH; Zheng, TT | 1 |
| Ding, D; Gai, C; Li, W; Li, Z; Lv, S; Yu, M; Zhang, W; Zheng, J | 1 |
| Chen, L; Dong, C; Han, Y; Hu, X; Liang, S; Lin, Y; Liu, J; Lu, Y; Shi, S; Wang, C; Yao, T; Zhou, L | 1 |
| Gadeval, A; Kalia, K; Kalyane, D; Maheshwari, R; Raval, N; Tekade, RK | 1 |
| Fang, H; Gai, Y; Gao, M; Hou, Y; Lan, X; Li, H; Li, M; Liu, Q; Wang, S; Yuan, L | 1 |
| Ashkavand, Z; Coleman, MF; Hursting, SD; Kok, DE; Krupenko, SA; O'Flanagan, CH | 1 |
| Carvalho, IC; Carvalho, SM; Krambrock, K; Lage, MCG; Leonel, AG; Lobato, ZIP; Mansur, AAP; Mansur, HS | 1 |
| Cross, V; Dircksen, C; Felten, A; Hahn, S; Johnson, T; Klein, P; Leamon, CP; Lu, J; Nelson, M; Parham, G; Pugh, M; Qi, L; Reddy, JA; Santhapuram, HK; Vaughn, JF; Vetzel, M; Vlahov, IR; Wang, K; Westrick, E | 1 |
| Ghosh, S; Sarkar, K; Sarkar, P | 1 |
| Chen, X; Coleman, MF; Hursting, SD; Krupenko, SA; O'Flanagan, CH; Pearce, JB; Pfeil, AJ; Sumner, S | 1 |
| Cé, R; Collares, T; Couto, GK; Dallemole, DR; Guterres, SS; Pacheco, BS; Pacheco, BZ; Paschoal, JD; Pohlmann, AR; Seixas, F | 1 |
| DeVaux, RS; Espinal, R; Hepel, M; Herschkowitz, JI; Kurzatkowska, K; Santiago, T | 1 |
| Bouchalova, K; Cwiertka, K; Horakova, D; Kollarova, H; Stepanek, L; Vlckova, J | 1 |
| Frontera, ED; Gorski, DH; Guerin-Edbauer, TJ; Khansa, RM; Leakan, LE; Ratnam, M; Schalk, DL; Speyer, CL | 1 |
| Bordbar, AK; Firuzi, O; Kayani, Z | 1 |
| Bardhan, S; Das, S; Dutta, A; Jana, K; Karmakar, P; Pal, K; Parida, PK; Roy, S | 1 |
| Bardhan, S; Dutta, A; Jana, K; Karmakar, P; Laha, D; Pal, K; Parida, PK; Roy, S | 1 |
| Allen, GO; Franco, VI; Gong, F; Hu, JJ; Lee, E; Levine, EA; Zhang, Y | 1 |
| Adhikary, A; Ahir, M; Bhattacharya, S; Chattopadhyay, S; Ghosh, S; Karmakar, S; Mukherjee, S; Mukhopadhyay, A; Patra, P | 1 |
| Ananta, JS; Bhethanabotla, R; Devulapally, R; Foygel, K; Joy, A; Massoud, TF; Mishra, K; Paulmurugan, R; Sekar, TV | 1 |
1 review(s) available for folic acid and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Risks and protective factors for triple negative breast cancer with a focus on micronutrients and infections.
Topics: Dietary Supplements; Early Detection of Cancer; Epstein-Barr Virus Infections; Female; Folic Acid; Humans; Micronutrients; Papillomavirus Infections; Risk Factors; Soybean Proteins; Triple Negative Breast Neoplasms; Work Schedule Tolerance | 2018 |
27 other study(ies) available for folic acid and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Folate-Targeted Monodisperse PEG-Based Conjugates Made by Chemo-Enzymatic Methods for Cancer Diagnosis and Treatment.
Topics: Animals; Cell Line, Tumor; Doxorubicin; Female; Flow Cytometry; Folic Acid; Humans; Male; Mice; Mice, Nude; Nanoparticles; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2021 |
Folic acid conjugated chitosan encapsulated palladium nanoclusters for NIR triggered photothermal breast cancer treatment.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Folic Acid; HEK293 Cells; Humans; Light; Nanoparticles; Palladium; Rutin; Temperature; Triple Negative Breast Neoplasms | 2022 |
Biodegradable and biocompatible subcutaneous implants consisted of pH-sensitive mebendazole-loaded/folic acid-targeted chitosan nanoparticles for murine triple-negative breast cancer treatment.
Topics: Animals; Chitosan; Folic Acid; Humans; Hydrogen-Ion Concentration; Mebendazole; Mice; Nanoparticles; Triple Negative Breast Neoplasms | 2022 |
Folic Acid-Functionalized Carbon Dot-Enabled Starvation Therapy in Synergism with Paclitaxel against Breast Cancer.
Topics: Carbon; Cell Line, Tumor; Folic Acid; Glucose; Glucose Oxidase; HEK293 Cells; Humans; Paclitaxel; Triple Negative Breast Neoplasms | 2022 |
Inhibition of Mitochondrial Biosynthesis Using a "Right-Side-Out" Membrane-Camouflaged Micelle to Facilitate the Therapeutic Effects of Shikonin on Triple-Negative Breast Cancer.
Topics: Animals; Cell Line, Tumor; Folic Acid; Humans; Mice; Micelles; Naphthoquinones; Organelle Biogenesis; Polyethylene Glycols; Triple Negative Breast Neoplasms | 2022 |
Combined inhibition of EZH2 and CD73 molecules by folic acid-conjugated SPION-TMC nanocarriers loaded with siRNA molecules prevents TNBC progression and restores anti-tumor responses.
Topics: Animals; Cell Line, Tumor; Chitosan; Enhancer of Zeste Homolog 2 Protein; Folic Acid; Humans; Magnetic Iron Oxide Nanoparticles; Mice; Nanoparticles; RNA, Small Interfering; Triple Negative Breast Neoplasms; Tumor Microenvironment | 2022 |
Overcoming the non-kinetic activity of EGFR1 using multi-functionalized mesoporous silica nanocarrier for in vitro delivery of siRNA.
Topics: Cell Line, Tumor; Drug Delivery Systems; ErbB Receptors; Folic Acid; Guanidine; Hormones; Humans; Ionic Liquids; Nanoparticles; Polyethylene Glycols; Polymers; RNA, Small Interfering; Silicon Dioxide; Triple Negative Breast Neoplasms | 2022 |
Hydroxyethyl starch-folic acid conjugates stabilized theranostic nanoparticles for cancer therapy.
Topics: Antineoplastic Agents; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Folic Acid; Humans; Nanoparticles; Precision Medicine; Prodrugs; Starch; Theranostic Nanomedicine; Triple Negative Breast Neoplasms; Tumor Microenvironment | 2023 |
Rhodiola rosea polysaccharides-based nanoparticles loaded with DOX boosts chemo-immunotherapy for triple-negative breast cancer by re-educating Tumor-associated macrophages.
Topics: Doxorubicin; Drug Carriers; Drug Delivery Systems; Folic Acid; Humans; Immunotherapy; Nanoparticles; Polysaccharides; Rhodiola; Triple Negative Breast Neoplasms; Tumor-Associated Macrophages | 2023 |
Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells.
Topics: Cell Death; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cysteine Dioxygenase; Drug Delivery Systems; Exosomes; Folic Acid; Gene Expression Regulation, Neoplastic; Glutathione Peroxidase; Humans; Phospholipid Hydroperoxide Glutathione Peroxidase; Piperazines; Reactive Oxygen Species; Triple Negative Breast Neoplasms | 2019 |
Tumor-Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel-Enhanced Immunotherapy with Polarization toward M1-Type Macrophages on Triple Negative Breast Cancers.
Topics: Animals; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Cell Survival; Copper; Docetaxel; Drug Carriers; Folic Acid; Humans; Immunotherapy; Lasers; Mice; Nanocomposites; Oligonucleotides; Phototherapy; Polyethyleneimine; Protoporphyrins; Reactive Oxygen Species; T-Lymphocytes, Cytotoxic; Triple Negative Breast Neoplasms | 2019 |
Green graphene nanoplates for combined photo-chemo-thermal therapy of triple-negative breast cancer.
Topics: Cell Line, Tumor; Folic Acid; Graphite; Green Chemistry Technology; Humans; Nanoparticles; Photochemotherapy; Quercetin; Triple Negative Breast Neoplasms | 2020 |
Red blood cell membrane-coated upconversion nanoparticles for pretargeted multimodality imaging of triple-negative breast cancer.
Topics: Animals; Biomimetic Materials; Cell Line, Tumor; Click Chemistry; Erythrocyte Membrane; Female; Fluorides; Folic Acid; Gadolinium; Humans; Magnetic Resonance Imaging; Mice; Multimodal Imaging; Nanoparticles; Neoplasm Transplantation; Phosphatidylethanolamines; Polyethylene Glycols; Positron-Emission Tomography; Triple Negative Breast Neoplasms; Ytterbium | 2020 |
Effects of folic acid withdrawal on transcriptomic profiles in murine triple-negative breast cancer cell lines.
Topics: Animals; Cell Line, Tumor; Culture Media; Epithelial-Mesenchymal Transition; Female; Folic Acid; Mice; Mice, Transgenic; Transcriptome; Triple Negative Breast Neoplasms; Wnt Signaling Pathway | 2020 |
Supramolecular magnetonanohybrids for multimodal targeted therapy of triple-negative breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Membrane Permeability; Combined Modality Therapy; Doxorubicin; Drug Liberation; Fluorescent Dyes; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Hyperthermia, Induced; Magnetic Fields; Magnetite Nanoparticles; Molecular Targeted Therapy; Nanocapsules; Optical Imaging; Prospective Studies; Reactive Oxygen Species; Theranostic Nanomedicine; Triple Negative Breast Neoplasms | 2020 |
Pre-clinical studies of EC2629, a highly potent folate- receptor-targeted DNA crosslinking agent.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Cattle; Cisplatin; Cross-Linking Reagents; DNA; Dogs; Drug Delivery Systems; Drug Design; Drug Evaluation, Preclinical; Endometrial Neoplasms; Female; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Inhibitory Concentration 50; KB Cells; Ligands; Mice; Mice, Inbred C57BL; Mice, Nude; Ovarian Neoplasms; Paclitaxel; Rats; Triple Negative Breast Neoplasms; Vinca Alkaloids; Xenograft Model Antitumor Assays | 2020 |
Folic acid based carbon dot functionalized stearic acid-g-polyethyleneimine amphiphilic nanomicelle: Targeted drug delivery and imaging for triple negative breast cancer.
Topics: Antibiotics, Antineoplastic; Carbon; Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Delivery Systems; Folic Acid; Humans; Micelles; Polyethyleneimine; Stearic Acids; Triple Negative Breast Neoplasms | 2021 |
Metabolic Response of Triple-Negative Breast Cancer to Folate Restriction.
Topics: Animals; Cell Line, Tumor; Diet Therapy; Female; Flow Cytometry; Folic Acid; Humans; Mammary Neoplasms, Experimental; Metabolomics; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Triple Negative Breast Neoplasms | 2021 |
Folic acid-doxorubicin polymeric nanocapsules: A promising formulation for the treatment of triple-negative breast cancer.
Topics: Apoptosis; Cell Line, Tumor; Doxorubicin; Folic Acid; Humans; Nanocapsules; Triple Negative Breast Neoplasms | 2021 |
Surface-enhanced Raman scattering investigation of targeted delivery and controlled release of gemcitabine.
Topics: Antineoplastic Agents; Cell Line, Tumor; Delayed-Action Preparations; Deoxycytidine; Doxorubicin; Drug Delivery Systems; Female; Folic Acid; Gemcitabine; Gold; Humans; Hydrogen-Ion Concentration; Metal Nanoparticles; Molecular Targeted Therapy; Spectrum Analysis, Raman; Transferrin; Triple Negative Breast Neoplasms | 2017 |
IgA Fc-folate conjugate activates and recruits neutrophils to directly target triple-negative breast cancer cells.
Topics: Antibody-Dependent Cell Cytotoxicity; Cell Line, Tumor; Female; Folate Receptor 1; Folic Acid; Humans; Immunoglobulin A; Neutrophils; Peroxidase; Receptors, Fc; Triple Negative Breast Neoplasms | 2018 |
Novel folic acid-conjugated doxorubicin loaded β-lactoglobulin nanoparticles induce apoptosis in breast cancer cells.
Topics: Antibiotics, Antineoplastic; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Carriers; Drug Liberation; Folic Acid; Humans; Lactoglobulins; MCF-7 Cells; Nanoparticles; Particle Size; Triple Negative Breast Neoplasms | 2018 |
Folic acid conjugated curcumin loaded biopolymeric gum acacia microsphere for triple negative breast cancer therapy in invitro and invivo model.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Curcumin; Drug Delivery Systems; Female; Folic Acid; Gum Arabic; Mice; Mice, Inbred BALB C; Microspheres; Triple Negative Breast Neoplasms | 2019 |
An
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Curcumin; Drug Carriers; Drug Delivery Systems; Folic Acid; Humans; Mice; Mice, Inbred BALB C; Microspheres; Nanoparticles; Triple Negative Breast Neoplasms | 2019 |
Combined genetic and nutritional risk models of triple negative breast cancer.
Topics: Adult; Aged; beta Carotene; Case-Control Studies; Diet; DNA Repair; Energy Intake; Female; Folic Acid; Folic Acid Deficiency; Gene-Environment Interaction; Genetic Predisposition to Disease; Humans; Logistic Models; Malnutrition; Micronutrients; Middle Aged; Multivariate Analysis; Nutrition Assessment; Pilot Projects; Polymorphism, Single Nucleotide; Risk Factors; Surveys and Questionnaires; Triple Negative Breast Neoplasms; Zinc | 2014 |
Tailored-CuO-nanowire decorated with folic acid mediated coupling of the mitochondrial-ROS generation and miR425-PTEN axis in furnishing potent anti-cancer activity in human triple negative breast carcinoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chick Embryo; Copper; Female; Folic Acid; Humans; Mice; Mice, Inbred BALB C; MicroRNAs; Mitochondria; Nanowires; PTEN Phosphohydrolase; Reactive Oxygen Species; Triple Negative Breast Neoplasms | 2016 |
Folate Receptor-Targeted Polymeric Micellar Nanocarriers for Delivery of Orlistat as a Repurposed Drug against Triple-Negative Breast Cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Packaging; Drug Repositioning; Folic Acid; Gene Expression Regulation, Neoplastic; Humans; Lactones; Mice; Mice, Nude; Micelles; Nanoparticles; Orlistat; Triple Negative Breast Neoplasms | 2016 |